We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLB icon
751
Dolby
DLB
$4.69B
$425K ﹤0.01%
7,077
-285
-4% -$18K
PLUS icon
752
ePlus
PLUS
$2.33B
$425K ﹤0.01%
5,642
+152
+3% +$12.5K
IRMD icon
753
iRadimed
IRMD
$1.21B
$424K ﹤0.01%
4,403
-937
-18% -$93.7K
EXPO icon
754
Exponent
EXPO
$2.96B
$424K ﹤0.01%
6,494
-287
-4% -$20.4K
MANH icon
755
Manhattan Associates
MANH
$9.48B
$424K ﹤0.01%
3,183
+406
+15% +$60.8K
RVLV icon
756
Revolve Group
RVLV
$1.8B
$423K ﹤0.01%
18,719
-661
-3% -$17.3K
KNSL icon
757
Kinsale Capital Group
KNSL
$7.82B
$423K ﹤0.01%
1,238
-54
-4% -$20.5K
CALM icon
758
Cal-Maine
CALM
$4.17B
$423K ﹤0.01%
5,340
-328
-6% -$26.9K
HLI icon
759
Houlihan Lokey
HLI
$9.72B
$420K ﹤0.01%
2,927
+144
+5% +$23.7K
HRMY icon
760
Harmony Biosciences
HRMY
$2.12B
$420K ﹤0.01%
14,997
+1,560
+12% +$51.2K
SN icon
761
SharkNinja
SN
$21B
$420K ﹤0.01%
+3,964
New +$464K
SPSC icon
762
SPS Commerce
SPSC
$2.3B
$418K ﹤0.01%
7,515
+1,687
+29% +$122K
APAM icon
763
Artisan Partners
APAM
$2.78B
$418K ﹤0.01%
11,478
-199
-2% -$8.14K
HL icon
764
Hecla Mining
HL
$10.1B
$417K ﹤0.01%
+22,396
New +$504K
WHD icon
765
Cactus
WHD
$3.8B
$417K ﹤0.01%
8,806
-2,405
-21% -$126K
NSSC icon
766
Napco Security Technologies
NSSC
$1.3B
$415K ﹤0.01%
10,544
-1,283
-11% -$53.8K
MKTX icon
767
MarketAxess Holdings
MKTX
$4.01B
$412K ﹤0.01%
2,500
-381
-13% -$66.8K
DOCS icon
768
Doximity
DOCS
$3.78B
$412K ﹤0.01%
17,691
+7,443
+73% +$232K
GRBK icon
769
Green Brick Partners
GRBK
$3.04B
$412K ﹤0.01%
6,389
-1,120
-15% -$78.8K
SSD icon
770
Simpson Manufacturing
SSD
$7.61B
$412K ﹤0.01%
+2,399
New +$442K
HCSG icon
771
Healthcare Services Group
HCSG
$1.7B
$411K ﹤0.01%
+22,166
New +$438K
PGNY icon
772
Progyny
PGNY
$2.5B
$410K ﹤0.01%
24,165
+4,918
+26% +$105K
RIGL icon
773
Rigel Pharmaceuticals
RIGL
$725M
$410K ﹤0.01%
15,172
+3,971
+35% +$133K
COCO icon
774
Vita Coco
COCO
$4.31B
$409K ﹤0.01%
8,527
-1,042
-11% -$56.9K
CHE icon
775
Chemed
CHE
$6.65B
$408K ﹤0.01%
1,079
-51
-5% -$21.8K

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.